Amylyx Pharmaceuticals, Inc. (AMLX) vs Celcuity Inc. (CELC)

A side-by-side comparison of Amylyx Pharmaceuticals, Inc. and Celcuity Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Amylyx Pharmaceuticals, Inc. logo
AMLX
Amylyx Pharmaceuticals, Inc.
$3.09B
$27.82HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
Celcuity Inc. logo
CELC
Celcuity Inc.
$3.57B
$73.11HealthcareDelayed quote: Oct 6, 2026, 11:31 AM EDT

Total return — AMLX vs CELC

growth of $100 · dividends reinvested · last 5y
AMLX +53.7% (+9.0%/yr)CELC +481.1% (+42.2%/yr)CELC compounded faster over this window
05001kStart $1002023202420252026$154$581
AMLX CELC

AMLX vs CELC: by the numbers

  • •CELC is the larger company ($3.57B vs $3.09B market cap).

Metrics side by side

Valuation

MetricAMLXCELC
P/B ratio12.93N/A

Profitability

MetricAMLXCELC
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-63.59%N/A
ROIC-66.60%-28.15%

Growth (annualized)

MetricAMLXCELC
Total return CAGR (5Y)N/A34.40%

Go deeper

Full AMLX analysisFull CELC analysisInteractive comparison tool

Dig into the metrics

Amylyx Pharmaceuticals ROECelcuity ROEAmylyx Pharmaceuticals operating marginCelcuity operating marginAmylyx Pharmaceuticals revenue growthCelcuity revenue growthAmylyx Pharmaceuticals free cash flowCelcuity free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.